White Paper · Cannabis Tax · §280E

The 280E Problem After the 2026 Schedule III Rule: Tax Controls for Cannabis Operators

The 2026 Schedule III rule changes §280E for qualifying state-medical-marijuana activity, but it does not erase the statute for adult-use or other Schedule I marijuana. The operational challenge is turning that legal distinction into books, inventory records, forecasts and transaction documents that match the business.

By Lincoln Square Law · 8-minute read

Section 280E is a classification rule before it is an accounting problem

Internal Revenue Code section 280E disallows deductions and credits for a trade or business that consists of trafficking in controlled substances prohibited by federal or state law when the substances are in Schedule I or II.

For years, marijuana’s Schedule I status made that provision central to cannabis tax planning. The 2026 DEA rule changes the scheduling premise for defined medical activity but not for every cannabis business (26 U.S.C. § 280E, 91 Fed. Reg. 22714).

The final rule places marijuana subject to a state medical marijuana license in Schedule III, along with FDA-approved marijuana drug products. Other marijuana remains Schedule I. The first question for the controller is therefore legal: which entity and which revenue-producing activity are within the state-medical category?

Accounting cannot solve that question after the fact.

Create a license-and-revenue map before changing the chart of accounts. For each entity, identify the licenses it holds, the states in which it operates, whether each activity is medical or adult-use, the effective date of the rule, and the inventory or service flow associated with that activity. The tax workpaper should cite back to that map.

Qualifying medical activity has a different post-April 28 starting point

DEA states in the final rule that, as a consequence of moving marijuana subject to state medical marijuana licenses to Schedule III, covered state licensees will no longer be subject to the section 280E deduction disallowance. The statement follows the statutory fact that section 280E is limited to Schedule I and II substances.

The agency also states that nothing in its rule constitutes a determination of federal tax liability (91 Fed. Reg. 22714, 22719-20).

That caveat should shape the implementation. A business should not book a tax benefit merely because it possesses a cannabis license with the word “medical” somewhere in its portfolio. Confirm that the entity’s activity is actually conducted under a state medical marijuana license within the federal rule. Confirm the period to which the position applies. Then have tax counsel and the return preparer determine the tax treatment.

Operationally, the change may affect estimated tax payments, deferred tax assumptions, cash forecasts, debt covenants and transaction models. Those downstream numbers should follow the tax conclusion, not precede it. A legal memo and accounting model that reach opposite assumptions about the licensed activity create avoidable diligence risk.

Adult-use revenue is not swept into the medical rule

The final rule expressly leaves marijuana outside the covered FDA-approved and state-medical categories in Schedule I. Adult-use marijuana therefore remains inside the scheduling category referenced by section 280E. A mixed medical/adult-use business needs a method for identifying which activity is which and for supporting the tax consequences of that distinction.

The difficulty is not just revenue coding. The business may share cultivation rooms, manufacturing equipment, warehouses, management, marketing, software and retail premises. Those facts should be documented honestly.

Legal entities and operational separations that existed for genuine licensing and business reasons should be reflected consistently in the books. Artificial recharacterizations created only at tax time invite problems.

Create written rules for point-of-sale coding, transfers, inventory ownership and shared costs. Where professional judgment is required, document the methodology and authority relied on. The goal is not to invent a universal allocation rule. It is to ensure that the records are sufficient for tax advisers to apply the law to what the company actually did.

Do not treat DEA’s retrospective-relief discussion as a refund right

DEA’s final rule encourages Treasury to consider retrospective section 280E relief for taxable years in which a state licensee operated under a state medical marijuana license. The rule does not grant that relief. DEA also disclaims making a federal tax-liability determination. Until Treasury, the IRS, Congress or a court supplies controlling tax authority, operators should distinguish a policy statement from an available refund position.

Preserve the data necessary to evaluate future relief. Keep prior-year returns, 280E workpapers, license records, sales by medical and adult-use category, inventory workpapers and any examination correspondence. If later authority creates a path to relief, those records will determine whether an amended filing is possible and what amount can be supported.

Also address refund economics in transactions. A purchase agreement can specify who controls amended returns, who receives refunds, who bears audit risk and how tax benefits or liabilities attributable to pre-closing periods are allocated. Waiting until a future refund becomes real can turn a tax opportunity into a post-closing dispute.

Inventory accounting remains a separate discipline

Section 471 requires inventories when necessary to clearly determine income and directs inventory accounting toward methods that conform as nearly as possible to best accounting practice and clearly reflect income. That rule exists independently of section 280E. A cannabis company should therefore review inventory accounting after the Schedule III change rather than assuming that historical 280E workarounds or classifications remain the correct tax method (26 U.S.C. § 471).

For cultivators and manufacturers, tax records should reconcile to production records: purchases, direct labor where applicable, production stages, yields, waste, testing, transfers and finished goods. Retailers should reconcile beginning inventory, purchases, transfers and sales. The legal team does not decide the tax capitalization method, but it can help ensure that contracts, licenses and operational descriptions match what the tax team is modeling.

Avoid the phrase “everything is deductible now.” Even for qualifying medical activity, ordinary tax rules still determine whether a cost is currently deductible, capitalized, included in inventory, depreciated or treated another way. The disappearance of one disallowance does not replace the rest of the Internal Revenue Code.

Tax controls should be updated through change management

The April 28 rule should trigger a controlled update to tax-sensitive procedures. First, freeze the pre-change 280E methodology and preserve the workpapers. Second, approve a post-change classification map for covered medical activity. Third, update general-ledger coding and forecast assumptions prospectively. Fourth, document the treatment of mixed adult-use activity. Fifth, create an escalation rule for new licenses, new states and changes in product flow.

The same control should reach board materials and investor reporting. If management presents a materially lower cash-tax forecast, the assumptions should identify which operations are relying on the Schedule III rule and whether adult-use activity remains subject to 280E. That prevents an operationally narrow rule from becoming an enterprise-wide financial assumption by accident.

Finally, align the tax position with regulatory compliance. The DEA rule includes federal registration obligations for covered Schedule III handlers. A company should not claim the benefits of a Schedule III classification in one context while ignoring the compliance conditions that accompany the federally controlled activity.

For 2026, evidence is as important as the conclusion

A year with a mid-year federal change creates a recordkeeping problem even for a straightforward operator. The company needs to show what happened before April 28, what activity qualified afterward, and how the change flowed into returns and financial reporting. Preserve dated legal authority, state licenses, DEA registration material, accounting policies, workpapers and the management approval for the transition.

When the business expands, repeat the analysis rather than copying the old answer. A new state may structure medical licenses differently. An acquisition may bring adult-use-only entities into the group. A reorganization can change which taxpayer earns the revenue. The tax rule follows the facts and legal activity, not the brand name.

The Schedule III rule meaningfully changes the section 280E landscape for state-medical-marijuana businesses, but disciplined operators will treat that as a scoped legal change. The strongest tax file is one that can trace the result from federal schedule, to state license, to entity, to transaction, to ledger, to return.